Dapsone 25 mg
- Product NDC
- 83098-102
- 11-digit product format
- 830980102
- Labeler code
- 83098
- Product ID
- 83098-102_2127568d-553c-c142-e063-6394a90a4ef7
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Dapsone Tablets
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Everest Life Sciences. LLC
- Application
- ANDA086841
- Marketing category
- ANDA
- Marketing start
- 2024-09-01
- Substance
- DAPSONE
- Active strength
- 25 mg/1
- Pharmacologic classes
- Sulfone [EPC], Sulfones [CS]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Dapsone 25 mg
- Listing expiration
- 2027-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| DAPSONE | 25 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 8W5C518302 |
| Rxcui | 197557, 197558 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 83098-102-01 | Dapsone 25 mg | 100 in 1 BOTTLE | TABLET | 100 | | 2 |
| 83098-102-03 | Dapsone 25 mg | 30 in 1 BOTTLE | TABLET | 30 | | 2 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 83098-102 | DAPSONE 25 MG (DAPSONE TABLETS) TABLET DAPSONE 100 MG (DAPSONE TABLETS) TABLET [EVEREST LIFE SCIENCES. LLC] | 1 | Current NDC, 2 package rows | 20240902_1d026bb6-05da-e9cf-e063-6394a90a2485.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 83098-102-01 | 83098010201 | 100 TABLET in 1 BOTTLE (83098-102-01) | 100 tablet | 2024-09-01 | No | No | Current |
| 83098-102-03 | 83098010203 | 30 TABLET in 1 BOTTLE (83098-102-03) | 30 tablet | 2024-09-01 | No | No | Current |